138 related articles for article (PubMed ID: 12182355)
21. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
[TBL] [Abstract][Full Text] [Related]
22. Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: structure-function studies and inhibitor development.
Hong Y; Chen S
Mol Cell Endocrinol; 2011 Jul; 340(2):120-6. PubMed ID: 20888390
[TBL] [Abstract][Full Text] [Related]
23. On the inhibitory action of 29 drugs having side effect gynecomastia on estrogen production.
Satoh T; Itoh S; Seki T; Itoh S; Nomura N; Yoshizawa I
J Steroid Biochem Mol Biol; 2002 Oct; 82(2-3):209-16. PubMed ID: 12477487
[TBL] [Abstract][Full Text] [Related]
24. Widespread tissue distribution of steroid sulfatase, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD), 17 beta-HSD 5 alpha-reductase and aromatase activities in the rhesus monkey.
Martel C; Melner MH; Gagné D; Simard J; Labrie F
Mol Cell Endocrinol; 1994 Aug; 104(1):103-11. PubMed ID: 7821701
[TBL] [Abstract][Full Text] [Related]
25. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
[TBL] [Abstract][Full Text] [Related]
26. Effect of nomegestrol acetate on estrone-sulfatase and 17beta-hydroxysteroid dehydrogenase activities in human breast cancer cells.
Chetrite G; Paris J; Botella J; Pasqualini JR
J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):525-31. PubMed ID: 8918978
[TBL] [Abstract][Full Text] [Related]
27. Steroid sulfatase and 17 beta-hydroxysteroid oxidoreductase activities in mouse tissues.
Milewich L; Garcia RL; Gerrity LW
J Steroid Biochem; 1984 Nov; 21(5):529-38. PubMed ID: 6239954
[TBL] [Abstract][Full Text] [Related]
28. [Uterine estrogen sulfotransferase and estrogen sulfatase in embryo implantation].
Loza Arredondo MC; González Juarez NA
Ginecol Obstet Mex; 1994 Nov; 62():341-4. PubMed ID: 7821832
[TBL] [Abstract][Full Text] [Related]
29. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
30. The selective estrogen enzyme modulator (SEEM) in breast cancer.
Chetrite GS; Pasqualini JR
J Steroid Biochem Mol Biol; 2001; 76(1-5):95-104. PubMed ID: 11384867
[TBL] [Abstract][Full Text] [Related]
31. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.
Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE
J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796
[TBL] [Abstract][Full Text] [Related]
32. Retinoic acids promote the action of aromatase and 17beta-hydroxysteroid dehydrogenase type 1 on the biosynthesis of 17beta-estradiol in placental cells.
Zhu SJ; Li Y; Li H; Wang YL; Xiao ZJ; Vihko P; Piao YS
J Endocrinol; 2002 Jan; 172(1):31-43. PubMed ID: 11786372
[TBL] [Abstract][Full Text] [Related]
33. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).
Penning TM; Burczynski ME; Jez JM; Lin HK; Ma H; Moore M; Ratnam K; Palackal N
Mol Cell Endocrinol; 2001 Jan; 171(1-2):137-49. PubMed ID: 11165022
[TBL] [Abstract][Full Text] [Related]
34. Association of estrogen with glucocorticoid levels in visceral fat in postmenopausal women.
Yamatani H; Takahashi K; Yoshida T; Takata K; Kurachi H
Menopause; 2013 Apr; 20(4):437-42. PubMed ID: 23149864
[TBL] [Abstract][Full Text] [Related]
35. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
Aka JA; Mazumdar M; Lin SX
Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
[TBL] [Abstract][Full Text] [Related]
36. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
37. Intracrine control of estrogen action in human gestational tissues at parturition.
Madsen G; Zakar T; Manuelpillai U; Wallace E; Kwek K; Yeo GS; Smith R; Mesiano S
J Soc Gynecol Investig; 2004 May; 11(4):213-9. PubMed ID: 15120694
[TBL] [Abstract][Full Text] [Related]
38. Evolution of 17-β-estradiol, estrone and estrone-sulfate concentrations in late pregnancy of different breeds of mares using Liquid Chromatography and Mass Spectrometry.
Ledeck J; Dufour P; Evrard É; Le Goff C; Peeters S; Brutinel F; Egyptien S; Deleuze S; Cavalier É; Ponthier J
Theriogenology; 2022 Sep; 189():86-91. PubMed ID: 35738034
[TBL] [Abstract][Full Text] [Related]
39. Generation of estradiol within the pregnant guinea pig uterine compartment with special reference to the myometrium.
Hobkirk R; Glasier MA
J Steroid Biochem Mol Biol; 1993 Mar; 44(3):291-7. PubMed ID: 8461261
[TBL] [Abstract][Full Text] [Related]
40. An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples.
Geisler J; Ekse D; Helle H; Duong NK; Lønning PE
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):90-5. PubMed ID: 18242079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
